A reversible tracer analysis approach to the study of effective dopamine turnover

被引:60
作者
Sossi, V
Doudet, DJ
Holden, JE
机构
[1] Univ British Columbia, TRIUMF, Vancouver, BC V5Z 1M9, Canada
[2] Univ Wisconsin, Madison, WI USA
关键词
dopaminergic system; effective dopamine turnover; distribution volume ratio; modeling;
D O I
10.1097/00004647-200104000-00015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Changes in dopamine turnover resulting from disease states such as Parkinson's disease may be reflected in corresponding changes in the kinetics of the positron emission tomographic tracer [F-18]fluorodopa. The authors had previously refined the conventional irreversible-tracer graphical approach to determine both the uptake rate constant Ki and the rate constant k(loss) that describes the slow loss of the trapped kinetic component. Because these parameters change in the opposite sense with disease, their ratios may be more powerfully discriminating than either one alone. The ratio k(loss)/K-i is indicative of effective dopamine turnover. Its inverse, K-i/k(loss), can be interpreted as the effective distribution volume (EDV) of the specific uptake compartment referred to the fluorodopa concentration in plasma. Here the authors present a new approach to the estimation of EDV based on reversible-tracer graphical methods. When implemented with a plasma input function, the method evaluates EDV directly. When implemented with a tissue input function, the outcome is proportional to the ratio of the distribution volumes of the specific uptake and precursor compartments. Comparison of the new and previous approaches strongly validates this alternative approach to the study of effective dopamine turnover.
引用
收藏
页码:469 / 476
页数:8
相关论文
共 19 条
  • [1] THE RELATIONSHIP BETWEEN LOCOMOTOR DISABILITY, AUTONOMIC DYSFUNCTION, AND THE INTEGRITY OF THE STRIATAL DOPAMINERGIC SYSTEM IN PATIENTS WITH MULTIPLE SYSTEM ATROPHY, PURE AUTONOMIC FAILURE, AND PARKINSONS-DISEASE, STUDIED WITH PET
    BROOKS, DJ
    SALMON, EP
    MATHIAS, CJ
    QUINN, N
    LEENDERS, KL
    BANNISTER, R
    MARSDEN, CD
    FRACKOWIAK, RSJ
    [J]. BRAIN, 1990, 113 : 1539 - 1552
  • [2] Cumming P, 1998, SYNAPSE, V29, P37, DOI 10.1002/(SICI)1098-2396(199805)29:1<37::AID-SYN4>3.0.CO
  • [3] 2-C
  • [4] Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: A PET study with 6-[F-18]L-DOPA
    Doudet, DJ
    Chan, GLY
    Holden, JE
    Pate, BD
    Morrison, KS
    Calne, DB
    Ruth, TJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 334 (01) : 31 - 38
  • [5] Doudet DJ, 1998, SYNAPSE, V29, P225, DOI 10.1002/(SICI)1098-2396(199807)29:3<225::AID-SYN4>3.0.CO
  • [6] 2-8
  • [7] Holden JE, 1997, J NUCL MED, V38, P1568
  • [8] KINETICS AND MODELING OF L-6-[F-18] FLUORO-DOPA IN HUMAN POSITRON EMISSION TOMOGRAPHIC STUDIES
    HUANG, SC
    YU, DC
    BARRIO, JR
    GRAFTON, S
    MELEGA, WP
    HOFFMAN, JM
    SATYAMURTHY, N
    MAZZIOTTA, JC
    PHELPS, ME
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1991, 11 (06) : 898 - 913
  • [9] Ishikawa T, 1996, J NUCL MED, V37, P216
  • [10] HUMAN STRIATAL L-DOPA DECARBOXYLASE ACTIVITY ESTIMATED INVIVO USING 6-[F-18]FLUORO-DOPA AND POSITRON EMISSION TOMOGRAPHY - ERROR ANALYSIS AND APPLICATION TO NORMAL SUBJECTS
    KUWABARA, H
    CUMMING, P
    REITH, J
    LEGER, G
    DIKSIC, M
    EVANS, AC
    GJEDDE, A
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1993, 13 (01) : 43 - 56